NASDAQ · UPXI

Upexi, Inc.

$0.80 -$0.01 (-0.73%) 1D After hours

Key Metrics

$59.21M
Market cap
P/E · TTM
$26.14M
Revenue · TTM
−$228.45M
Net income
EPS · TTM $-3.77
Dividend yield
Free cash flow −$21.76M
Beta · 1Y 4.38
EBITDA · TTM −$218.93M
Gross margin 87.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 4
    The stock moved +37.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 4
  • Feb 25
    The stock moved +36.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 25
  • Feb 23
    From its Jan 29 high, the share price fell 69%.

    Peak close $1.83 on Jan 29; trough close $0.57 on Feb 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -69%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$59.21M
Enterprise value
Shares outstanding73.5M
52-wk range$0.54 – $9.12
Avg volume · 20D1.7M
Net cash
Book value / share$-0.86
IndustryFinance Services
ExchangeNASDAQ
About Upexi, Inc.
IPO dateJun 24, 2021
Employees59

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.27
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 87.0%
Operating -839.8%
Net -874.0%
FCF -83.2%
ROE / ROIC 440.0% · —

Financial Health

Current ratio1.72
Quick ratio1.72
Debt / equity
Debt / EBITDA
Net cash
Working capital$50.98M

Cash Flow · TTM

Operating CF −$21.52M
Capex −$233.76K
Free cash flow −$21.76M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings